Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis

Romero, Rodrigo, Sayin, Volkan I, Davidson, Shawn M, Bauer, Matthew R, Singh, Simranjit X, LeBoeuf, Sarah E, Karakousi, Triantafyllia R, Ellis, Donald C +20 more·2017·Nature Medicine

DOI 10.1038/nm.4407

Cited by (664)

Items 301–400 of 664

Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma
Jinfeng Ning, Fengjiao Wang, Jianlong Bu, Kaibin Zhu, Wei Liu · 2022 · Cell Death Discovery
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
Akira Ooki, Hiroki Osumi, Keisho Chìn, Masayuki Watanabe, Kensei Yamaguchi · 2023 · Therapeutic Advances in Medical Oncology
Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy
Yuli Ge, Qiong Zhou, Fan Pan, Rui Wang · 2025 · International Journal of Nanomedicine
Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
Yuta Adachi, Ryo Kimura, Kentaro Hirade, Hiromichi Ebi · 2021 · Cancers
Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma
I. Kawakami, Hirofumi Yoshino, Wataru Fukumoto, Motoki Tamai, Shunsuke Okamura, Yoichi Osako, Takashi Sakaguchi, Satoru Inoguchi, Ryosuke Matsushita, Yasutoshi Yamada et al. · 2022 · Biochemical and Biophysical Research Communications
Nutritional Stress in Head and Neck Cancer Originating Cell Lines: The Sensitivity of the NRF2-NQO1 Axis
Lidija Milković, Marko Tomljanović, Ana Čipak Gašparović, Renata Novak Kujundžić, Dina Šimunić, Paško Konjevoda, Anamarija Mojzeš, Nikola Đaković, Neven Žarković, Koraljka Gall‐Tros̆elj · 2019 · Cells
RPB5‐Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding
Zhenghua Wan, Tianyi Jiang, Yuanyuan Shi, Yufei Pan, Yun‐Kai Lin, Yunhan Ma, Chun Yang, Xiao‐Fan Feng, Lifeng Huang, Xiaoni Kong et al. · 2019 · Hepatology
Shining a light on metabolic vulnerabilities in non-small cell lung cancer
Dowling, Catríona M., Zhang, Hua, Chonghaile, Tríona Ní, Wong, Kwok-Kin · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export
Hoon Choi, Mamta Gupta, Arjun Sengupta, Emma Elizabeth Furth, Christopher Hensley, Aalim M. Weljie, Hsiaoju S. Lee, Yuting Lu, Austin Pantel, David A. Mankoff et al. · 2025 · Neoplasia
Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells
Shibo Sun, Yue Zhang, Weiping Xu, Rui Yang, Yijia Yang, Jianli Guo, Qiang Ma, Kun Ma, Jie Zhang, Jianqiang Xu · 2021 · Biomedicine & Pharmacotherapy
Novel NRF2 ‐activated cancer treatments utilizing synthetic lethality
Liam Baird, Thomas W. Kensler, Masayuki P. Yamamoto · 2022 · IUBMB Life
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Christoph Arolt, Margaret Han Dugan, Robert Wild, Vanessa Richartz, Barbara Holz, Andreas Hans Scheel, Johannes Brägelmann, Svenja Wagener‐Ryczek, Sabine Merkelbach‐Bruse, Juergen Wolf et al. · 2023 · Journal of Thoracic Oncology
A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells
Liam Baird, Keiko Taguchi, Anqi Zhang, Yushi Takahashi, Takafumi Suzuki, Thomas W. Kensler, Masayuki P. Yamamoto · 2023 · Redox Biology
Does Tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Kemp H. Kernstine, Brandon Faubert, Quyen N. Do, Thomas J. Rogers, Christopher T. Hensley, Ling Cai, Jose R. Torrealba, Dwight Oliver, Jason Wachsmann, Robert E. Lenkinski et al. · 2019 · The Annals of Thoracic Surgery
SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational Research
Anthony Lima, Danilo Maddalo · 2021 · Frontiers in Oncology
Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development
Anna Arnal Estape, Giorgia Foggetti, Jacqueline H. Starrett, Don X. Nguyen, Katerina A. Politi · 2021 · Cold Spring Harbor Perspectives in Medicine
Nanoparticles (NPs)-mediated targeted regulation of redox homeostasis for effective cancer therapy
Zixuan Zhao, Yuan Cao, Rui Fang Xu, Junyue Fang, Yuxuan Zhang, Xiaoding Xu, Linzhuo Huang, Rong Li · 2024 · Smart Materials in Medicine
The redox sensor KEAP1 facilitates adaptation of T cells to chronic antigen stimulation by preventing hyperactivation
Ziang Zhu, Ying Luo, Guohua Lou, Kiddist D. Yihunie, Safuwra Wizzard, Andrew DeVilbiss, Sarah Muh, Chaoyu Ma, Sejal S. Shinde, Jonathan Hoar et al. · 2024 · Science Immunology
Metabolic reprogramming in lung cancer and its clinical implication
Qingqiu Huang, Lisha Fan, Mingjing Gong, Jun Tao Ren, Chen Chen, Shenglong Xie · 2024 · Frontiers in Pharmacology
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
Steffan Vartanian, James Lee, Christiaan N. Klijn, Florian Gnad, Maria Bagniewska, Gabriele Schaefer, Donglu Zhang, Jenille Tan, Sara A. Watson, Liling Liu et al. · 2019 · Cancer Research
KEAP1 Mutations Drive Tumorigenesis by Suppressing SOX9 Ubiquitination and Degradation
Na Shao, Hong Huang, Muhammad Idris, Peng Xu, Feng Xu, Shiwu Dong, Chungang Liu · 2020 · Advanced Science
Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells
Adelina Plangger, Barbara Rath, Maximilian Johannes Hochmair, Martin A. Funovics, Gerhard Hamilton · 2021 · Translational Oncology
RETRACTED: CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment
Fatima Akram, Ikram ul Haq, Sania Sahreen, Narmeen Nasir, Waqas Naseem, Memoona Imitaz, Amna Aqeel · 2022 · Technology in Cancer Research & Treatment · Retracted
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
Waseem Chauhan, Rahima Zennadi · 2023 · Antioxidants
Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2‐mutant lung cancer
Mei‐Chun Cai, Minjiang Chen, Pengfei Ma, Jie Wu, Haijiao Lu, Shengzhe Zhang, Jin Liu, Xiaojing Zhao, Guanglei Zhuang, Zhuang Yu et al. · 2018 · International Journal of Cancer
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Zhao, Dan, Li, Haiqing, Mambetsariev, Isa, Mirzapoiazova, Tamara, Chen, Chen, Fricke, Jeremy, Kulkarni, Prakash, Villaflor, Victoria, Arvanitis, Leonidas, Hamilton, Stanley et al. · 2022 · Cancers
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies
Luigi Liguori, Fabio Salomone, Angela Viggiano, Francesco Sabbatino, Stefano Pepe, Luigi Formisano, Roberto Bianco, Alberto Servetto · 2024 · Critical Reviews in Oncology/Hematology
Targeting Nutrient Dependency in Cancer Treatment
Kexin Fan, Zhan Liu, Min Gao, Kangsheng Tu, Qiuran Xu, Yilei Zhang · 2022 · Frontiers in Oncology
Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting
Claudia Cerella, Mario A. Dicato, Marc F. Diederich · 2023 · Pharmacological Research
The Impact of Diet on the Involvement of Non-Coding RNAs, Extracellular Vesicles, and Gut Microbiome-Virome in Colorectal Cancer Initiation and Progression
Bene Akromaa Ekine-Afolabi, Anoka Ayembe Njan, Solomon O. Rotimi, Anu R I, Mohammad Attia Elbehi, Elizabeth D. Cash, Ademola Adetoyese Adeyeye · 2020 · Frontiers in Oncology
Lipid Peroxidation-Related Redox Signaling in Osteosarcoma
Suzana Borović Šunjić, Morana Jaganjac, Josipa Vlainić, Mirna Halasz, Neven Žarković · 2024 · International Journal of Molecular Sciences
Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
Qingsong Wang, Liang Xu, Gang Wang, Lei Chen, Changping Li, Xiangli Jiang, Hai Gao, Bing Yang, Weiping Tian · 2020 · PLoS ONE
KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer
Kristen Suzanne Hill, Anthony McDowell, Joseph Robert McCorkle, Erin E. Schuler, Sally R. Ellingson, Rina Plattner, Jill Kolesar · 2021 · Cancers
RUNX3-mediated circDYRK1A inhibits glutamine metabolism in gastric cancer by up-regulating microRNA-889-3p-dependent FBXO4
Haofeng Liu, Qiu Xue, Hongzhou Cai, Xiaohui Jiang, Guangxin Cao, Tie Chen, Yuan Chen, Ding Wang · 2022 · Journal of Translational Medicine
The Role of Nrf2/sMAF Signalling in Retina Ageing and Retinal Diseases
Jialing Zhang, Ting Zhang, Shaoxue Zeng, Xinyuan Zhang, Fanfan Zhou, Mark C. Gillies, Ling Zhu · 2023 · Biomedicines
Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors
Dimitris Karagiannis, Warren Wu, Albert Mao Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav S. Mangipudy, Xinjing Xu, Francisco J. Sánchez Rivera, Yadira M. Soto‐Feliciano et al. · 2023 · Cell Reports
Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
Lee Jy, Richie Rashmin Bhandare, Sai H. S. Boddu, AFZAL BASHA SHAIK, Lakshmana Prabu Saktivel, Gaurav Gupta, Poonam Negi, Muna M. Barakat, Sachin Kumar Singh, Kamal Dua et al. · 2024 · Biomedicine & Pharmacotherapy
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells
Juan de los Santos-Jiménez, José Angel Campos-Sandoval, Francisco José Alonso, Javier Márquez, José Manuel Matés · 2024 · Antioxidants
Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology
Yingchao Liu, Sainan Li, Yunyi Wu, Ping Zhang, Yanhua Yu, Xi Chen, Lingyan Yu, Xinyi Yang, Yanchun Li, Cuiyun Wu et al. · 2025 · Cellular & Molecular Biology Letters
Effects of antioxidants on cancer progression
Sarah Schmidt, Xi Qiao, Martin O. Bergö · 2025 · EMBO Molecular Medicine
CRISPR and KRAS: a match yet to be made
Guzide Bender, Rezan Fahrioglu Yamaci, Bahar Taneri · 2021 · Journal of Biomedical Science
Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
Noriaki Sunaga, Yosuke Miura, Norimitsu Kasahara, Reiko Sakurai · 2021 · Cancers
Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2
Marek Samec, Alena Mazuráková, Vincent Lučanský, Lenka Koklesová, Renata Péčová, Martin Jozef Péč, Olga Golubnitschaja, Raghad Khalid AL-Ishaq, Martin Čaprnda, Ľudovít Gašpar et al. · 2023 · European Journal of Pharmacology
Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer
Zhi Zeng, Ziyao Wang, Yukun Li, Dongmei Ye, Juan Zeng, Jiali Hu, Pi-feng Chen, Jiao Xiao, Juan Zou, Zhenhua Li · 2020 · Life Sciences
Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers
Kasey R. Cargill, William L. Hasken, Carl Michael Gay, Lauren A. Byers · 2021 · Frontiers in Oncology
Mechanisms used by cancer cells to tolerate drug-induced replication stress
Hendrika A. Segeren, Bart Westendorp · 2022 · Cancer Letters
Integrated metabolomics and phosphoproteomics reveal the protective role of exosomes from human umbilical cord mesenchymal stem cells in naturally aging mouse livers
Mingying Ling, Cong-min Tang, Xuechun Yang, Na Yu, Yiping Song, Wenjing Ding, Yan Sun, Rong Yan, Shaopeng Wang, Xuehui Li et al. · 2023 · Experimental Cell Research
Mitochondrial-Encoded Complex I Impairment Induces a Targetable Dependency on Aerobic Fermentation in Hürthle Cell Carcinoma of the Thyroid
Anderson R. Frank, Vicky Li, Spencer D. Shelton, Jiwoong Kim, Gordon M. Stott, Leonard Μ. Neckers, Yang Xie, Noelle Sevilir Williams, Prashant Mishra, David G. McFadden · 2023 · Cancer Discovery
Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
Aditya Kumar Sharma, Anil Kumar Giri · 2024 · Frontiers in Genetics
FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
Kai Yuan, Yanyan Feng, Hesong Wang, Lu Zhao, Wei Ting Wang, Ting Wang, Yuyin Feng, Guangrui Huang, Anlong Xu · 2020 · PeerJ
Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‑mutated lung cancer cells
Mei Wang, Xu Chen, Guang Fu, Mingjian Ge · 2022 · Oncology Reports · Retracted
Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy
Yanyu Jiang, Shuaishuai Ni, Biying Xiao, Lijun Jia · 2023 · Acta Pharmaceutica Sinica B
CRISPR activation screens identify the SWI/SNF ATPases as suppressors of ferroptosis
Kamakoti P. Bhat, Jinchu Vijay, Caroline K. Vilas, Jyoti Asundi, Jun Zou, Ted Lau, Xiaoyu Tracy Cai, Musaddeque Ahmed, Michał Kabza, Julie Weng et al. · 2024 · Cell Reports
Applications of CRISPR systems in respiratory health: Entering a new ‘red pen’ era in genome editing
Colette Moses, Parwinder Kaur · 2019 · Respirology
Everolimus in the treatment of metastatic thymic epithelial tumors
Jessica A. Hellyer, Madhu Micheal Ouseph, Sukhmani Kaur Padda, Heather A. Wakelee · 2020 · Lung Cancer
NRF2 signaling in cytoprotection and metabolism
Shohei Murakami, Yusuke Kusano, Keito Okazaki, Takaaki Akaike, Hozumi Motohashi · 2023
Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis
Eun Ji Lee, Krishna Babu Duggirala, Yujin Lee, Mi Ran Yun, Jiyoon Jang, Rajath Cyriac, Myoung Eun Jung, Gildon Choi, Chong Hak Chae, Byoung Chul Cho et al. · 2022 · Bioorganic & Medicinal Chemistry Letters
Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells
Ting‐Wan Kao, Yao-Chen Chuang, Hsin‐Lun Lee, Chia‐Chun Kuo, Yao Shen · 2022 · International Journal of Molecular Sciences
Established, emerging and elusive molecular targets in the treatment of lung cancer
Jean‐Nicolas Gallant, Christine Marie Lovly · 2018 · The Journal of Pathology
Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments
Masayo Yoshimura, Kurumi Seki, Andrey Bychkov, Junya Fukuoka · 2021 · Frontiers in Oncology
NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
Sean Michael O'Cathail, Chieh‐Hsi Wu, Rachael J. Thomas, M. Hawkins, Tim Maughan, Annabelle Lewis · 2021 · Antioxidants
Targeting Therapy Resistance: When Glutamine Catabolism Becomes Essential
Michael J. Lukey, William P. Katt, Richard A. Cerione · 2018 · Cancer Cell
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
Ceder, Sophia, Eriksson, Sofi E., Liang, Ying Yu, Cheteh, Emarndeena H., Zhang, Si Min, Fujihara, Kenji M., Bianchi, Julie, Bykov, Vladimir J. N., Abrahmsen, Lars, Clemons, Nicholas J. et al. · 2021 · Cell Death & Disease
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
Aiman B. Awan, Maryiam Jama Ali Osman, Omar M. Khan · 2025 · Cells
Modification in Structures of Active Compounds in Anticancer Mitochondria-Targeted Therapy
Agnieszka Felczykowska, Anna Herman-Antosiewicz · 2025 · International Journal of Molecular Sciences
Free Radicals in Health and Disease
Xiaofeng Dai, Zizheng Huang, Ruohan Lyu · 2025 · MedComm
The integrated stress response promotes immune evasion through lipocalin 2
Jozef P. Bossowski, Ray Pillai, John Kilian, Angela Wong Lau, Mari Nakamura, Ali Rashidfarrokhi, Yuan Hao, Ruxuan Li, Katherine Wu, Takamitsu Hattori et al. · 2026 · Nature
NRF2 and the Moirai: Life and Death Decisions on Cell Fates
Yoko Yagishita, Dionysios V. Chartoumpekis, Thomas W. Kensler, Nobunao Wakabayashi · 2022 · Antioxidants and Redox Signaling
Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review
Maya M. Moubarak, Antonio C. Pagano Zottola, Claire M. Larrieu, Sylvain Cuvellier, Thomas Daubon, Océane C. B. Martin · 2023 · Neuro-Oncology Advances
Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function
Jun A. Takahashi, Takafumi Suzuki, Miu Sato, Shuji Nitta, Nahoko Yaguchi, Tatsuki Muta, Kouhei Tsuchida, Hiromi Suda, Masanobu Morita, Shin Hamada et al. · 2024 · Cell Reports
Efficient and multiplexed somatic genome editing with Cas12a mice
Jess D. Hebert, Haiqing Xu, Yuning J. Tang, Paloma A. Ruiz, Colin R. Detrick, Jing Wang, Nicholas W. Hughes, Oscar Donosa, Vicky P Siah, Laura Andrejka et al. · 2025 · Nature Biomedical Engineering
Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung
Bo Zhang, Zhiyuan Ma, Biqin Tan, Nengming Lin · 2018 · Expert Opinion on Therapeutic Targets
Targeting Metabolic Bottlenecks in Lung Cancer
Volkan I. Sayin, Sarah E. LeBoeuf, Thales Y. Papagiannakopoulos · 2019 · Trends in cancer
Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer
Kanchan Singh, Melissa A. Pruski, Kishore Polireddy, Neal C. Jones, Qingzheng Chen, Jun Yao, Wasim A. Dar, Florencia M. McAllister, Cynthia Ju, Holger K. Eltzschig et al. · 2019 · Oncogene
NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer
Sean Michael O'Cathail, Chieh‐Hsi Wu, Annabelle Lewis, Chris C. Holmes, M. Hawkins, Tim Maughan · 2020 · Cancer Genetics
Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease
Xingguo Zhu, Aluya Oseghale, Lopez H Nicole, Yaqin Li, Betty S. Pace · 2019 · Experimental Biology and Medicine
Distinct roles for the thioredoxin and glutathione antioxidant systems in Nrf2-Mediated lung tumor initiation and progression
Amanda Sherwood, Basma A. Yasseen, Janine M. DeBlasi, Samantha Caldwell, Gina M. DeNicola · 2025 · Redox Biology
Drug Discovery Oncology in a Mouse: concepts, Models and Limitations
Jason E. Long, Maja Jankovic, Danilo Maddalo · 2021 · Future Science OA
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, John J. Newland, Xi Chen, Wen Xu, Ashkan Emadi, Joseph S. Friedberg, Richard L. Eckert · 2022 · Molecular Carcinogenesis
AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis
Bing Deng, Fang Liu, Nana Chen, Xinhao Li, Jie Lei, Ning Chen, Jingjing Wu, Xuan Wang, Jie Lu, Mouxiang Fang et al. · 2024 · Cell Death and Disease
Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
Bhargav Shreevatsa, Chandan Dharmashekara, Vikas Halasumane Swamy, Meghana V. Gowda, Raghu Ram Achar, Vivek Hamse Kameshwar, Rajesh Kumar Thimmulappa, Asad Syed, Abdallah Mohamed Elgorban, Salim Saleh Al-Rejaie et al. · 2021 · Molecules
Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
Xianguang Bai, Ming Yi, Xichao Xia, Shengnan Yu, Xinhua Zheng, Kongming Wu · 2018 · Cancer Management and Research
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
Samera Hussein Hamad, Stephanie A. Montgomery, Jeremy M. Simon, Brittany M. Bowman, Kyle B. Spainhower, Ryan M. Murphy, Erik S. Knudsen, Suzanne E. Fenton, Scott H. Randell, Jeremiah Ray Holt et al. · 2022 · Oncogene
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Douglas B. Fox, Richard Y. Ebright, Xin Hong, Hunter C. Russell, Hongshan Guo, Thomas James LaSalle, Ben S. Wittner, Nicolas Poux, Joanna A. Vuille, Mehmet Toner et al. · 2023 · npj Precision Oncology
The Complex Roles of Redox and Antioxidant Biology in Cancer
Makiko Hayashi, Keito Okazaki, Thales Papgiannakopoulos, Hozumi Motohashi · 2024 · Cold Spring Harbor Perspectives in Medicine
Epigenetic Mechanisms Governing Nrf2 Expression and Its Role in Ferroptosis
Linbo Li, Xinjun Liu, Zizhen Si, Xidi Wang · 2025 · Biomedicines
Mechanisms and therapeutic potential of disulphidptosis in cancer
Yanhu Li, Haijun Zhang, Fengguang Yang, Daxue Zhu, Shijie Chen, Zhaoheng Wang, Ziyan Wei, Zhili Yang, Jingwen Jia, Yizhi Zhang et al. · 2024 · Cell Proliferation
Alterations in plasma concentrations of energy-balance-related metabolites in patients with lung, or head & neck, cancers: Effects of radiotherapy
Elisabet Rodríguez‐Tomàs, Monica Arguís, Meritxell Arenas, Salvador Fernández‐Arroyo, M. Murcia, S. Sabater, L. Torres, Gerard Baiges‐Gayà, Anna Hernández‐Aguilera, Jordi Camps et al. · 2019 · Journal of Proteomics
NRF2-Driven KEAP1 Transcription in Human Lung Cancer
Yijun Tian, Qian Liu, Shengnan Yu, Qian Chu, Yuan Chen, Kongming Wu, Liang Wang · 2020 · Molecular Cancer Research
H2S probe CPC inhibits autophagy and promotes apoptosis by inhibiting glutathionylation of Keap1 at Cys434
Na Li, JuYuan Wang, Xiaoling Zang, Zhaoyang Wang, Tao Zhang, Bao‐Xiang Zhao, Jun‐Ying Miao, Zhao‐Min Lin · 2021 · APOPTOSIS
Genetic, metabolic and immunological features of cancers with NRF2 addiction
Hiroshi Kitamura, Haruna Takeda, Hozumi Motohashi · 2022 · FEBS Letters
Differential glutamine metabolism in the tumor microenvironment – studies in diversity and heterogeneity: A mini-review
Michael D. Claiborne, Robert D. Leone · 2022 · Frontiers in Oncology
Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer
Niki Karachaliou, Jillian Wilhelmina Paulina Bracht, Manuel Fernandez Bruno, Ana Drozdowskyj, Ana A. Giménez-Capitán, Teresa Morán, Enric Carcereny, Manuel Cobo, Manuel Dómine, Imane CHAIB-OUKADOUR et al. · 2018 · Journal of Thoracic Oncology
From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression
Sarah Graham, Mariia Dmitrieva, Debora Barbosa Vendramini Costa, Ralph Francescone, María Aurora Martínez Trujillo, Edna Cukierman, Laura DeLong Wood · 2024 · Carcinogenesis
Unique and overlapping roles of NRF2 and NRF1 in transcriptional regulation
Hiroki Sekine, Hozumi Motohashi · 2023 · Journal of Clinical Biochemistry and Nutrition
Kelch-like ECH-associated Protein 1/Nuclear Factor Erythroid 2-related Factor 2 Pathway and Its Interplay with Oncogenes in Lung Tumorigenesis
Taegeun Bae, Mi‐Kyoung Kwak · 2024 · Journal of Cancer Prevention
Roles of selenium-containing glutathione peroxidases and thioredoxin reductases in the regulation of processes associated with glioblastoma progression
Elena Gennadyevna Varlamova · 2025 · Archives of Biochemistry and Biophysics
CRISPR-Cas deployment in non-small cell lung cancer for target screening, validations, and discoveries
K. Sreedurgalakshmi, R. Srikar, Reena Rajkumari · 2020 · Cancer Gene Therapy
Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer
Dylan Farnsworth, Yankuan T. Chen, Georgia de Rappard-Yuswack, William Wirt Lockwood · 2021 · Cells
Transcriptomics pave the way into mechanisms of cobalt and nickel toxicity: Nrf2-mediated cellular responses in liver carcinoma cells
Alicia Thiel, Franziska Drews, Marcello Pirritano, Fabian Schumacher, Vivien Michaelis, Maria Schwarz, Sören Franzenburg, Tanja Schwerdtle, Bernhard Michalke, Anna Patricia Kipp et al. · 2024 · Redox Biology